基本信息
浏览量:6
职业迁徙
个人简介
Liver fibrosis and its end-stage sequelae of cirrhosis and liver cancer are major causes of morbidity and mortality in Australia and throughout the world and their prevalence is rising, largely due to the increasing impact of chronic liver diseases including non-alcoholic fatty liver disease (NAFLD) and biliary diseases. It is hoped better disease prevention and more effective therapies will help reduce this disease burden. However, there remains a major need to identify potentially modifiable factors which exacerbate liver injury and fibrosis and to develop therapies that can prevent or slow liver scarring. This is particularly true for NAFLD, a disease which affects up to 30% of the adult population and is now a major cause of the premature illness and death, but for which there is still no established drug therapy.
研究兴趣
论文共 239 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Brooke Chapman,Su Kah Goh, Frank Parker,Sarah Romero,Marie Sinclair,Paul Gow, Ronald Ma,Peter Angus,Robert Jones,Jacqueline Luke,Vijayaragavan Muralidharan,Adam Testro
FRONTIERS IN PHYSIOLOGY (2022): 864083-864083
Indu G Rajapaksha,Lakmie S Gunarathne,Khashayar Asadi,Ross Laybutt, Sof Andrikopoulous,Ian E Alexander, Mathew J Watt,Peter W Angus,Chandana B Herath
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn